HIKAL
|
The Current P/B Ratio of HIKAL is 2.24.
| Share Price | ₹217.9 | Aug 14,2026 |
| Market Cap | ₹2,686.7 Cr | |
| Book Value | ₹1,198.8 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.24x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹2,686.7 Cr] as on Aug 14,2026
(/) Book Value [ ₹1,198.8 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.24x ]
Thus, for HIKAL , the investors are currently willing to pay '2.24 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.26x.
- HIKAL 's operated at median p/b ratio of 3.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2021 of 1.9x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| HIKAL | 1,198.80 | 2.24 | 2,686.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.53 | 461,848.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 13.46 | 225,648.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 21.95 | 184,109.0 |
| CIPLA LTD | 34,369.40 | 3.41 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.66 | 100,328.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.15 | 99,945.0 |
| LUPIN LTD | 22,384.10 | 4.57 | 102,192.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.19 | 113,715.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.52 | 95,397.6 |
| LAURUS LABS LTD | 5,275.08 | 18.59 | 98,064.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.24x |
| Max industry PB | 21.95x |
| Median industry PB | 4.57x |
| Average industry PB | 7.75x |
You may also like the below Video Courses